Promising therapeutic role of miR-27b in tumor

Tumour Biol. 2017 Mar;39(3):1010428317691657. doi: 10.1177/1010428317691657.

Abstract

MicroRNAs are small nonprotein-encoding RNAs ranging from 18 to 25 nucleotides in size and regulate multiple biological pathways via directly targeting a variety of associated genes in cancers. MicroRNA-27b is a highly conserved MicroRNA throughout vertebrates and there are two homologs (hsa-miR-27a and hsa-miR-27b) in humans. MicroRNA-27b is an intragenic microRNA located on chromosome 9q22.1 within the C9orf3 gene, clustering with miR-23b and miR-24-1 in human. As a frequently dysregulated microRNA in human cancers, microRNA-27b could function as a tumor suppressor or an oncogenic microRNA. More and more studies indicate that microRNA-27b is involved in affecting various biological processes, such as angiogenesis, proliferation, metastasis, and drug resistance, and thus may act as a promising therapeutic target in human cancers. In this review, we discuss the role of microRNA-27b in detail and offer novel insights into molecular targeting therapy for cancers.

Keywords: MicroRNA; biomarker; cancer; microRNA-27b; therapy.

Publication types

  • Review

MeSH terms

  • Cell Movement / genetics
  • Cell Proliferation / genetics*
  • Gene Expression Regulation, Neoplastic
  • Genes, Tumor Suppressor
  • Humans
  • MicroRNAs / biosynthesis
  • MicroRNAs / genetics*
  • Molecular Targeted Therapy
  • Neoplasms / genetics*
  • Neoplasms / pathology
  • Neoplasms / therapy
  • Neovascularization, Pathologic / genetics*
  • Neovascularization, Pathologic / pathology

Substances

  • MIRN27 microRNA, human
  • MicroRNAs